Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVenture Life Regulatory News (VLG)

Share Price Information for Venture Life (VLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.50
Ask: 41.50
Change: 0.00 (0.00%)
Spread: 1.00 (2.469%)
Open: 41.00
High: 41.00
Low: 41.00
Prev. Close: 41.00
VLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Benecol Supplement Capsule Sale Malta

9 Dec 2014 07:00

RNS Number : 1662Z
Venture Life Group PLC
09 December 2014
 



 

 

Venture Life Group plc

("Venture Life" or "the Group")

First sale of new Benecol® cholesterol-lowering capsules in Malta

 

Bracknell, UK - 9 December 2014: Venture Life Group plc (AIM: VLG), the international consumer products group addressing the self-care needs of the ageing population, announces the first sale of its new Benecol® food supplement capsules. This follows the signing of a distribution agreement earlier this year between Venture Life and Alf Mizzi & Sons (Marketing) Group ("Alf Mizzi") under which Venture Life granted Alf Mizzi exclusive distribution rights to Benecol in capsule form in Malta. Benecol is a registered trademark of Raisio plc and is licensed to Alf Mizzi in Malta.

 

The new Benecol food supplement in capsule form is being sold through pharmacies in Malta with particular promotion to doctors, healthcare specialists and pharmacists. Benecol products are proven to reduce low density lipo-protein (LDL) cholesterol, and in capsule form the product offers the consumer portability, convenience and a long shelf life.

 

Malta is the first market to launch the new Benecol food supplement in capsule form using Raisio's patented plant stanol ingredient and under the Benecol brand.

 

Alf Mizzi is the largest FMCG distributor in Malta and has been selling Benecol as a functional food (in yogurt drink and spread form) for over seven years. It has built a market leading position in Malta with Benecol yogurt drinks.

 

Jerry Randall, Chief Executive Officer of Venture Life, commented:

"This is a very significant landmark for Venture Life. Malta is the first territory where the new food supplement, in capsule form, is available alongside a functional food version of Benecol that is already well-established in the local market.

 

"We share Alf Mizzi's confidence that the distribution of the Benecol capsule will increase the overall market for the brand in Malta, and we look forward to working with Alf Mizzi as they build their Benecol business further in this new distribution channel."

 

 

- Ends -

 

  

 

For further information please contact:

Venture Life Group PLC

Jerry Randall, Chief Executive Officer

James Hunter, Chief Financial Officer +44 (0) 1344 742870

 

Panmure Gordon (UK) Limited Freddy Crossley / Duncan Monteith +44 (0) 20 7886 2500Corporate Finance

Tom SalvesenCorporate Broking

 

Square1 Consulting

David Bick

Mark Longson +44 (0) 20 7929 5599

 

 

Notes to editors

 

About Venture Life

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercializing products for the ageing population. The Group's product range and pipeline currently include food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin. The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

 

Through its manufacturing company, Biokosmes, the Group also provides development and manufacturing services to companies in the medical device and cosmetic sectors.

The Group's own branded products are currently sold or partnered in over 40 countries and currently include:

· food supplements to maintain brain function and memory;

· dermo-cosmetics for addressing the signs of skin ageing and hair loss, and

· medical devices for improving conditions such as minor aches and pains, dry eyes and itchy skin.

 

The Company has a healthy development pipeline including products in areas such as diabetes, cardiovascular health, obesity, cognitive function and skin ageing. Products coming from the pipeline will be expected to have intellectual property protection and be supported by independent clinical evidence of efficacy.

About Raisio plc and Benecol®

Raisio plc is a Finnish company, whose shares are listed on NASDAQ OMX Helsinki Ltd. Benecol is Raisio's top innovation. It is an original expert in cholesterol lowering functional foods. The brand was launched in Finland in 1995 and is now sold in some 30 countries worldwide. Benecol, originally introduced as a spread, has expanded into various food forms; yogurts, yogurt drinks, breads and cream cheese spreads.

 

Benecol products contain the unique and patented ingredient - Plant stanol ester. This ingredient is safe, natural and supported by more than 70 published clinical studies that demonstrate significant efficacy of the cholesterol lowering properties of the product.

 

Venture Life has developed a capsule form of Benecol that contains the recommended daily dosage levels of Plant stanol ester. Benecol trademark is licensed to Venture Life by Raisio in certain countries.

 

About Alf Mizzi

Alf Mizzi was founded in 1915 as a food and clothing importer and distributor. The family run business has grown, diversified and established itself as a leading company in Malta, with over 900 employees.

 

Within the FMCG sector, Alf Mizzi is the market leader in Malta, marketing and distributing globally recognised chilled, frozen and grocery food brands. Alf Mizzi invests extensively in marketing across multiple channels; TV, online and outdoor advertising, and distributes to small local stores as well as supermarkets.

 

Alf Mizzi has been distributing Benecol products in functional food form in supermarkets and other food stores since 2007. With the launch of Benecol capsules, Alf Mizzi is extending its distribution into the pharmacy channel, which will complement its existing Benecol product distribution.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAQVLFBZLFBFBK
Date   Source Headline
18th Mar 201611:04 amRNS'1000 Companies to Inspire Britain 2016' report
7th Mar 20167:00 amRNSCompletion of Acquisition
3rd Mar 20167:00 amRNSDirector/PDMR Shareholding
1st Mar 201612:07 pmRNSResult of General Meeting and Issue of Equity
18th Feb 201610:20 amRNSDirectorate Change
12th Feb 20165:38 pmRNSCircular Publication & Notice of General Meeting
12th Feb 201612:11 pmRNSResults of Placing to Partially Fund Acquisition
12th Feb 20167:00 amRNSProposed Placing and issue of Convertible Bonds
13th Jan 20167:00 amRNSProduct Launch
23rd Dec 20157:38 amRNSTrading Update
29th Sep 20157:00 amRNSInterim Results
9th Sep 20157:00 amRNSNotice of Results
9th Jul 20157:00 amRNSPre-Close Trading Statement
10th Jun 201511:41 amRNSAGM Statement
9th Jun 20157:00 amRNSStrategic Development and Commercial Alliance
22nd May 20157:00 amRNSPDMR Shareholding
15th Apr 20157:00 amRNS2014 Annual Report and Dividend Timetable
25th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSSale of trademarks: manufacturing agreement signed
26th Jan 20157:00 amRNS30-year exclusive distribution deal signed
9th Dec 20147:00 amRNSBenecol Supplement Capsule Sale Malta
4th Dec 201411:54 amRNSHolding(s) in Company
28th Nov 20147:00 amRNSShare Placing
19th Nov 20147:00 amRNSAppointment of Nominated Adviser and Broker
10th Oct 20147:00 amRNSDirector's Dealings
8th Oct 20147:00 amRNSDirector Dealings
6th Oct 20147:00 amRNSDirectors' Dealings
1st Oct 20147:00 amRNSInvestor Forum
29th Sep 20147:00 amRNSInterim Results
23rd Sep 20147:00 amRNSNew distribution agreements
5th Sep 20147:00 amRNSNotice of Interim Results
6th Aug 20147:00 amRNSNew Product Development and Board Change
7th Jul 20147:00 amRNSNew distribution agreement signed
30th Jun 201412:09 pmRNSAGM Statement
30th Jun 20147:00 amRNSTotal Voting Rights
25th Jun 20147:00 amRNSNew distribution agreements signed
17th Jun 20147:00 amRNSAppointment of Non-Executive Director
13th Jun 20149:44 amRNSHolding(s) in Company
5th Jun 20147:01 amRNSIssue of new shares
5th Jun 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSNew Distribution Agreement
28th Mar 20148:00 amRNSAdmission to AIM and Acquisition of Biokosmes Srl

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.